University of Dundee

Enabling the discovery of new drugs and their development to treat major global diseases


Working with a consortium of public sector agencies and six of the world’s leading pharmaceutical companies, the University’s unique research methods are accelerating and enhancing the process of discovering new drugs to treat a series of major global diseases which kill and harm millions each year. The University offers a one-stop shop to the pharmaceutical industry, giving access to knowledge both about a key enzyme family, whose activities have implications for cancer, diabetes, cardiovascular and inflammatory diseases and allergies, and about drug development targeting that enzyme family. Its innovative knowledge transfer programme has already yielded commercial benefits to all the parties involved.